<article title='Biotechnology'><paragraph><template><target>other uses</target><arg>Biotechnology (disambiguation)</arg></template><template><target>Redirect</target><arg>Bioscience</arg><arg>the scientific journal</arg><arg>BioScience</arg><arg>life sciences generally</arg><arg>life science</arg></template><link><target>File:Insulincrystals.jpg</target><part>thumb</part><part><link><target>Insulin</target></link><space/>crystals</part></link></paragraph><paragraph><bold>Biotechnology</bold><space/>is the use of living systems and organisms to develop or make products, or &quot;any technological application that uses biological systems, living organisms or derivatives thereof, to make or modify products or processes for specific use&quot; (UN Convention on Biological Diversity, Art. 2).<extension extension_name='ref'><link type='external' href='http://www.cbd.int/convention/text/'>Text of the CBD</link>. CBD.int. Retrieved on 2013-03-20.</extension><space/>Depending on the tools and applications, it often overlaps with the (related) fields of<space/><link><target>bioengineering</target></link>,<space/><link><target>biomedical engineering</target></link>, etc.</paragraph><paragraph>For thousands of years, humankind has used biotechnology in<space/><link><target>agriculture</target></link>,<space/><link><target>food production</target></link>, and<space/><link><target>medicine</target></link>.<extension extension_name='ref' name="BioREACH"><link type='external' href='http://www.public.asu.edu/~langland/biotech-intro.html'>&quot;Incorporating Biotechnology into the Classroom What is Biotechnology?&quot;, from the curricula of the 'Incorporating Biotechnology into the High School Classroom through Arizona State University's BioREACH program', accessed on October 16, 2012)</link>. Public.asu.edu. Retrieved on 2013-03-20.</extension><space/>The term is largely believed to have been coined in 1919 by Hungarian<space/><link><target>engineer</target></link><space/><link><target>Kroly Ereky</target></link>. In the late 20th and early 21st century, biotechnology has expanded to include new and diverse<space/><link><target>science</target><trail>s</trail></link><space/>such as<space/><link><target>genomics</target></link>,<space/><link><target>recombinant gene</target></link><space/>techniques, applied<space/><link><target>immunology</target></link>, and development of<space/><link><target>pharmaceutical</target></link><space/>therapies and<space/><link><target>diagnostic tests</target></link>.<extension extension_name='ref' name="BioREACH"></extension></paragraph><heading level='2'>Definitions</heading><paragraph>The wide concept of &quot;biotech&quot; or &quot;biotechnology&quot; encompasses a wide range of procedures for modifying living organisms according to human purposes, going back to<space/><link><target>domestication</target></link><space/>of animals, cultivation of plants, and &quot;improvements&quot; to these through breeding programs that employ<space/><link><target>artificial selection</target></link><space/>and<space/><link><target>Hybrid (biology)</target><part>hybridization</part></link>. Modern usage also includes<space/><link><target>genetic engineering</target></link><space/>as well as<space/><link><target>cell culture</target><part>cell</part></link><space/>and<space/><link><target>tissue culture</target></link><space/>technologies. The<space/><link><target>American Chemical Society</target></link><space/>defines biotechnology as the application of biological organisms, systems, or processes by various industries to learning about the science of life and the improvement of the value of materials and organisms such as pharmaceuticals, crops, and livestock.<extension extension_name='ref'><link type='external' href='http://portal.acs.org/portal/acs/corg/content?_nfpb=true&amp;amp;_pageLabel=PP_ARTICLEMAIN&amp;amp;node_id=1188&amp;amp;content_id=CTP_003377&amp;amp;use_sec=true&amp;amp;sec_url_var=region1&amp;amp;__uuid=5a1c54a6-ff5a-4f69-84c1-763835d11162'>Biotechnology</link>. Portal.acs.org. Retrieved on 2013-03-20.</extension><space/>As per<space/><link><target>European Federation of Biotechnology</target></link>, Biotechnology is the integration of natural science and organisms, cells, parts thereof, and molecular analogues for products and services.<extension extension_name='ref'><link type='external' href='http://nvsrochd.gov.in/s_club/biology/ch11_bilas.pdf'></link></extension>Biotechnology also writes on the pure biological sciences (<link><target>animal cell culture</target></link>,<space/><link><target>biochemistry</target></link>,<space/><link><target>cell biology</target></link>,<space/><link><target>embryology</target></link>,<space/><link><target>genetics</target></link>,<space/><link><target>microbiology</target></link>, and<space/><link><target>molecular biology</target></link>). In many instances, it is also dependent on knowledge and methods from outside the sphere of biology including:</paragraph><list type='bullet'><listitem><link><target>bioinformatics</target></link>, a new brand of<space/><link><target>computer science</target></link></listitem><listitem><link><target>bioprocess engineering</target></link></listitem><listitem><link><target>biorobotics</target></link></listitem><listitem><link><target>chemical engineering</target></link></listitem></list><paragraph>Conversely, modern biological sciences (including even concepts such as<space/><link><target>molecular ecology</target></link>) are intimately entwined and heavily dependent on the methods developed through biotechnology and what is commonly thought of as the<space/><link><target>life sciences</target></link><space/>industry. Biotechnology is the<space/><link><target>research and development</target></link><space/>in the<space/><link><target>laboratory</target></link><space/>using<space/><link><target>bioinformatics</target></link><space/>for exploration, extraction, exploitation and production from any<space/><link><target>living organisms</target></link><space/>and any source of<space/><link><target>biomass</target></link><space/>by means of<space/><link><target>biochemical engineering</target></link><space/>where high value-added products could be planned (reproduced by<space/><link><target>biosynthesis</target></link>, for example), forecasted, formulated, developed, manufactured and marketed for the purpose of sustainable operations (for the return from bottomless initial investment on R &amp; D) and gaining durable patents rights (for exclusives rights for sales, and prior to this to receive national and international approval from the results on animal experiment and human experiment, especially on the<space/><link><target>pharmaceutical</target></link><space/>branch of biotechnology to prevent any undetected side-effects or safety concerns by using the products).<extension extension_name='ref'><link type='external' href='http://www.europabio.org/what-biotechnology'>What is biotechnology?</link>. Europabio. Retrieved on 2013-03-20.</extension><extension extension_name='ref'><link type='external' href='http://www.oecd.org/science/innovationinsciencetechnologyandindustry/49303992.pdf'>KEY BIOTECHNOLOGY INDICATORS (December 2011)</link>. oecd.org</extension><extension extension_name='ref'><link type='external' href='http://www.oecd.org/sti/biotechnologypolicies/keybiotechnologyindicators.htm'>Biotechnology policies Organization for Economic Co-operation and Development</link>. Oecd.org. Retrieved on 2013-03-20.</extension></paragraph><paragraph>By contrast,<space/><link><target>bioengineering</target></link><space/>is generally thought of as a related field that more heavily emphasizes higher systems approaches (not necessarily the altering or using of biological materials<space/><italics>directly</italics>) for interfacing with and utilizing living things. Bioengineering is the application of the principles of engineering and natural sciences to tissues, cells and molecules. This can be considered as the use of knowledge from working with and manipulating biology to achieve a result that can improve functions in plants and animals.<extension extension_name='ref'><link type='external' href='http://www.bionewsonline.com/k/what_is_bioengineering.htm'>What Is Bioengineering?</link>. Bionewsonline.com. Retrieved on 2013-03-20.</extension><space/>Relatedly,<space/><link><target>biomedical engineering</target></link><space/>is an overlapping field that often draws upon and applies<space/><italics>biotechnology</italics><space/>(by various definitions), especially in certain sub-fields of biomedical and/or chemical engineering such as<space/><link><target>tissue engineering</target></link>, bio<link><target>pharmaceutical engineering</target></link>, and<space/><link><target>genetic engineering</target></link>.</paragraph><heading level='2'>History</heading><paragraph><link><target>File:The Brewer designed and engraved in the Sixteenth. Century by J Amman.png</target><part>right</part><part>thumb</part><part><link><target>Brewing</target></link><space/>was an early application of biotechnology</part></link></paragraph><paragraph><template><target>Main</target><arg>History of biotechnology</arg></template></paragraph><paragraph>Although not normally what first comes to mind, many forms of human-derived<space/><link><target>agriculture</target></link><space/>clearly fit the broad definition of &quot;'utilizing a biotechnological system to make products&quot;. Indeed, the cultivation of plants may be viewed as the earliest biotechnological enterprise.</paragraph><paragraph><link><target>Agriculture</target></link><space/>has been theorized to have become the dominant way of producing food since the<space/><link><target>Neolithic Revolution</target></link>. Through early biotechnology, the earliest farmers selected and bred the best suited crops, having the highest yields, to produce enough food to support a growing population. As crops and fields became increasingly large and difficult to maintain, it was discovered that specific organisms and their by-products could effectively<space/><link><target>fertilize</target></link>,<space/><link><target>nitrogen fixation</target><part>restore nitrogen</part></link>, and<space/><link><target>pesticide</target><part>control pests</part></link>. Throughout the history of agriculture, farmers have inadvertently altered the genetics of their crops through introducing them to new environments and<space/><link><target>plant breeding</target><part>breeding</part></link><space/>them with other plants one of the first forms of biotechnology.</paragraph><paragraph>These processes also were included in early<space/><link><target>Fermentation (biochemistry)</target><part>fermentation</part></link><space/>of<space/><link><target>beer</target></link>.<extension extension_name='ref'>See Arnold, John P. (2005) [1911]. Origin and History of Beer and Brewing: From Prehistoric Times to the Beginning of Brewing Science and Technology. Cleveland, Ohio: BeerBooks. p. 34. ISBN 978-0-9662084-1-2. OCLC 71834130.</extension><space/>These processes were introduced in early<space/><link><target>Mesopotamia</target></link>,<space/><link><target>Egypt</target></link>,<space/><link><target>China</target></link><space/>and<space/><link><target>India</target></link>, and still use the same basic biological methods. In<space/><link><target>brewing</target></link>, malted grains (containing<space/><link><target>enzymes</target></link>) convert starch from grains into sugar and then adding specific<space/><link><target>yeasts</target></link><space/>to produce beer. In this process,<space/><link><target>carbohydrates</target></link><space/>in the grains were broken down into alcohols such as ethanol. Later other cultures produced the process of<space/><link><target>lactic acid fermentation</target></link><space/>which allowed the fermentation and preservation of other forms of food, such as<space/><link><target>soy sauce</target></link>. Fermentation was also used in this time period to produce<space/><link><target>leavened bread</target></link>. Although the process of fermentation was not fully understood until<space/><link><target>Louis Pasteur</target></link>'s work in 1857, it is still the first use of biotechnology to convert a food source into another form.</paragraph><paragraph>Before the time of<space/><link><target>Charles Darwin</target></link>'s work and life, animal and plant scientists had already used selective breeding. Darwin added to that body of work with his scientific observations about the ability of science to change species. These accounts contributed to Darwin's theory of natural selection.<extension extension_name='ref'><template><target>Cite journal</target><arg name="url"><space/>http://www.encyclopedia.com/doc/1G2-3404200058.html</arg><arg name="title"><space/>Biotechnology</arg><arg name="last"><space/>Cole-Turner</arg><arg name="first"><space/>Ronald</arg><arg name="date"><space/>2003</arg><arg name="journal"><space/>Encyclopedia of Science and Religion</arg><arg name="accessdate"><space/>7 December 2014</arg><arg name="doi"><space/></arg><arg name="pmid"><space/></arg></template></extension></paragraph><paragraph>For thousands of years, humans have used selective breeding to improve production of crops and livestock to use them for food. In selective breeding, organisms with desirable characteristics are mated to produce offspring with the same characteristics. For example, this technique was used with corn to produce the largest and sweetest crops.<extension extension_name='ref' name="Thieman"><template><target>cite book</target><arg name="author">Thieman, W.J.; Palladino, M.A.<space/></arg><arg name="title">Introduction to Biotechnology<space/></arg><arg name="publisher">Pearson/Benjamin Cummings<space/></arg><arg name="year">2008<space/></arg><arg name="isbn">0-321-49145-9<space/></arg></template></extension></paragraph><paragraph>In the early twentieth century scientists gained a greater understanding of<space/><link><target>microbiology</target></link><space/>and explored ways of manufacturing specific products. In 1917,<space/><link><target>Chaim Weizmann</target></link><space/>first used a pure microbiological culture in an industrial process, that of manufacturing<space/><link><target>corn starch</target></link><space/>using<space/><italics><link><target>Clostridium acetobutylicum</target></link>,</italics><space/>to produce<space/><link><target>acetone</target></link>, which the<space/><link><target>United Kingdom</target></link><space/>desperately needed to manufacture<space/><link><target>explosive</target><trail>s</trail></link><space/>during<space/><link><target>World War I</target></link>.<extension extension_name='ref' name="Springham_biotechnology"><template><target>cite book</target><arg name="author">Springham, D.; Springham, G.; Moses, V.; Cape, R.E.<space/></arg><arg name="title">Biotechnology: The Science and the Business<space/></arg><arg name="url">https://books.google.com/books?id</arg><arg name="date">24 August 1999<space/></arg><arg name="publisher">CRC Press<space/></arg><arg name="isbn">978-90-5702-407-8<space/></arg><arg name="page">1</arg></template></extension></paragraph><paragraph>Biotechnology has also led to the development of antibiotics. In 1928,<space/><link><target>Alexander Fleming</target></link><space/>discovered the mold<space/><italics><link><target>Penicillium</target></link></italics>. His work led to the purification of the antibiotic compound formed by the mold by Howard Florey, Ernst Boris Chain and Norman Heatley - to form what we today know as<space/><link><target>penicillin</target></link>. In 1940, penicillin became available for medicinal use to treat bacterial infections in humans.<extension extension_name='ref' name="Thieman"></extension></paragraph><paragraph>The field of modern biotechnology is generally thought of as having been born in 1971 when Paul Berg's (Stanford) experiments in gene splicing had early success. Herbert W. Boyer (Univ. Calif. at San Francisco) and Stanley N. Cohen (Stanford) significantly advanced the new technology in 1972 by transferring genetic material into a bacterium, such that the imported material would be reproduced. The commercial viability of a biotechnology industry was significantly expanded on June 16, 1980, when the<space/><link><target>United States Supreme Court</target></link><space/>ruled that a<space/><link><target>genetic engineering</target><part>genetically modified</part></link><space/><link><target>microorganism</target></link><space/>could be<space/><link><target>patent</target><trail>ed</trail></link><space/>in the case of<space/><italics><link><target>Diamond v. Chakrabarty</target></link></italics>.<extension extension_name='ref' name="DiamondvChakrabarty">&quot;<link type='external' href='http://caselaw.lp.findlaw.com/scripts/getcase.pl?court=us&amp;amp;vol=447&amp;amp;invol=303'>Diamond v. Chakrabarty, 447 U.S. 303 (1980). No. 79-139</link>.&quot;<space/><italics><link><target>United States Supreme Court</target></link>.</italics><space/>June 16, 1980. Retrieved on May 4, 2007.</extension><space/>Indian-born Ananda Chakrabarty, working for<space/><link><target>General Electric</target></link>, had modified a bacterium (of the<space/><italics><link><target>Pseudomonas</target></link></italics><space/>genus) capable of breaking down crude oil, which he proposed to use in treating oil spills. (Chakrabarty's work did not involve gene manipulation but rather the transfer of entire organelles between strains of the<space/><italics>Pseudomonas</italics><space/>bacterium.</paragraph><paragraph>Revenue in the industry is expected to grow by 12.9% in 2008. Another factor influencing the biotechnology sector's success is improved intellectual property rights legislationand enforcementworldwide, as well as strengthened demand for medical and pharmaceutical products to cope with an ageing, and ailing, U.S. population.<extension extension_name='ref'><link type='external' href='https://web.archive.org/web/20080402034432/http://www.ibisworld.com/pressrelease/pressrelease.aspx?prid=115'>VoIP Providers And Corn Farmers Can Expect To Have Bumper Years In 2008 And Beyond, According To The Latest Research Released By Business Information Analysts At IBISWorld</link>. Los Angeles (March 19, 2008)</extension></paragraph><paragraph>Rising demand for biofuels is expected to be good news for the biotechnology sector, with the<space/><link><target>United States Department of Energy</target><part>Department of Energy</part></link><space/>estimating<space/><link><target>ethanol</target></link><space/>usage could reduce U.S. petroleum-derived fuel consumption by up to 30% by 2030. The biotechnology sector has allowed the U.S. farming industry to rapidly increase its supply of corn and soybeansthe main inputs into biofuelsby developing genetically modified seeds which are resistant to pests and drought. By boosting farm productivity, biotechnology plays a crucial role in ensuring that biofuel production targets are met.<extension extension_name='ref'><link type='external' href='http://www.bio-medicine.org/biology-technology-1/The-Recession-List---Top-10-Industries-to-Fly-and-Flop-in-2008-4076-3/'>The Recession List Top 10 Industries to Fly and Fl... (ith anincreasing share accounted for by ...)</link>, bio-medicine.org</extension></paragraph><heading level='2'>Examples</heading><paragraph><link><target>File:99341.jpg</target><part>thumb</part><part>A<space/><link><target>rose</target></link><space/>plant that began as cells grown in a tissue culture</part></link></paragraph><paragraph>Biotechnology has applications in four major industrial areas, including health care (medical), crop production and agriculture, non food (industrial) uses of crops and other products (e.g.<space/><link><target>biodegradable plastic</target><trail>s</trail></link>,<space/><link><target>vegetable oil</target></link>,<space/><link><target>biofuel</target><trail>s</trail></link>), and environmental uses.</paragraph><paragraph>For example, one application of biotechnology is the directed use of<space/><link><target>organism</target><trail>s</trail></link><space/>for the manufacture of organic products (examples include<space/><link><target>beer</target></link><space/>and<space/><link><target>milk</target></link><space/>products). Another example is using naturally present<space/><link><target>bacteria</target></link><space/>by the mining industry in<space/><link><target>bioleaching</target></link>. Biotechnology is also used to recycle, treat waste, clean up sites contaminated by industrial activities (<link><target>bioremediation</target></link>), and also to produce<space/><link><target>biological warfare</target><part>biological weapons</part></link>.</paragraph><paragraph>A series of derived terms have been coined to identify several branches of biotechnology; for example:</paragraph><list type='bullet'><listitem><bold><link><target>Bioinformatics</target></link></bold><space/>is an interdisciplinary field which addresses biological problems using computational techniques, and makes the rapid organization as well as analysis of biological data possible. The field may also be referred to as<space/><italics>computational biology</italics>, and can be defined as, &quot;conceptualizing biology in terms of molecules and then applying informatics techniques to understand and organize the information associated with these molecules, on a large scale.&quot;<extension extension_name='ref' name="gerstein">Gerstein, M. &quot;<link type='external' href='http://www.primate.or.kr/bioinformatics/Course/Yale/intro.pdf'>Bioinformatics Introduction</link>.&quot;<space/><italics><link><target>Yale University</target></link>.</italics><space/>Retrieved on May 8, 2007.</extension><space/>Bioinformatics plays a key role in various areas, such as<space/><link><target>functional genomics</target></link>,<space/><link><target>structural genomics</target></link>, and<space/><link><target>proteomics</target></link>, and forms a key component in the biotechnology and pharmaceutical sector.</listitem><listitem><bold><link><target>Blue biotechnology</target></link></bold><space/>is a term that has been used to describe the marine and aquatic applications of biotechnology, but its use is relatively rare.</listitem><listitem><bold><link><target>Green biotechnology</target></link></bold><space/>is biotechnology applied to agricultural processes. An example would be the selection and domestication of plants via<space/><link><target>micropropagation</target></link>. Another example is the designing of<space/><link><target>transgenic plant</target><trail>s</trail></link><space/>to grow under specific environments in the presence (or absence) of chemicals. One hope is that green biotechnology might produce more environmentally friendly solutions than traditional<space/><link><target>industrial agriculture</target></link>. An example of this is the engineering of a plant to express a<space/><link><target>pesticide</target></link>, thereby ending the need of external application of pesticides. An example of this would be<space/><link><target>Transgenic maize</target><part>Bt corn</part></link>. Whether or not green biotechnology products such as this are ultimately more environmentally friendly is a topic of considerable debate.</listitem><listitem><bold><link><target>biopharmaceutical</target><part>Red biotechnology</part></link></bold><space/>is applied to medical processes. Some examples are the designing of organisms to produce<space/><link><target>antibiotic</target><trail>s</trail></link>, and the engineering of genetic cures through<space/><link><target>genetic manipulation</target></link>.</listitem><listitem><bold>White biotechnology</bold>, also known as industrial biotechnology, is biotechnology applied to<space/><link><target>Industry</target><part>industrial</part></link><space/>processes. An example is the designing of an organism to produce a useful chemical. Another example is the using of<space/><link><target>enzymes</target></link><space/>as industrial<space/><link><target>catalyst</target><trail>s</trail></link><space/>to either produce valuable chemicals or destroy hazardous/polluting chemicals. White biotechnology tends to consume less in resources than traditional processes used to produce industrial goods.<template><target>Citation needed</target><arg name="date">October 2009</arg></template></listitem></list><paragraph>The investment and economic output of all of these types of applied biotechnologies is termed as &quot;<link><target>bioeconomy</target></link>&quot;.</paragraph><heading level='3'>Medicine</heading><paragraph>In medicine, modern biotechnology finds applications in areas such as<space/><link><target>pharmaceutical drug</target></link><space/>discovery and production,<space/><link><target>pharmacogenomics</target></link>, and genetic testing (or genetic screening).<link><target>File:Microarray2.gif</target><part>thumb</part><part><link><target>DNA microarray</target></link><space/>chip some can do as many as a million blood tests at once</part></link></paragraph><paragraph><link><target>Pharmacogenomics</target></link><space/>(a combination of<space/><link><target>pharmacology</target></link><space/>and<space/><link><target>genomics</target></link>) is the technology that analyses how genetic makeup affects an individual's response to drugs.<extension extension_name='ref'>Ermak G., Modern Science &amp; Future Medicine (second edition), 164 p., 2013</extension><space/>It deals with the influence of<space/><link><target>genetics</target><part>genetic</part></link><space/>variation on drug response in patients by correlating<space/><link><target>gene expression</target></link><space/>or<space/><link><target>single-nucleotide polymorphism</target><trail>s</trail></link><space/>with a drug's<space/><link><target>efficacy</target></link><space/>or<space/><link><target>toxicity</target></link>.<extension extension_name='ref' name="pmid20836007"><template><target>cite journal</target><arg name="author"><space/>Wang L<space/></arg><arg name="title"><space/>Pharmacogenomics: a systems approach<space/></arg><arg name="journal"><space/>Wiley Interdiscip Rev Syst Biol Med<space/></arg><arg name="volume"><space/>2<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>3–22<space/></arg><arg name="year"><space/>2010<space/></arg><arg name="pmid"><space/>20836007<space/></arg><arg name="doi"><space/>10.1002/wsbm.42<space/></arg></template></extension><space/>By doing so, pharmacogenomics aims to develop rational means to optimize drug therapy, with respect to the patients'<space/><link><target>genotype</target></link>, to ensure maximum efficacy with minimal<space/><link><target>adverse effect (medicine)</target><part>adverse effects</part></link>.<extension extension_name='ref' name="pmid19530963"><template><target>cite journal</target><arg name="author"><space/>Becquemont L<space/></arg><arg name="title"><space/>Pharmacogenomics of adverse drug reactions: practical applications and perspectives<space/></arg><arg name="journal"><space/>Pharmacogenomics<space/></arg><arg name="volume"><space/>10<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>961–9<space/></arg><arg name="date">June 2009<space/></arg><arg name="pmid"><space/>19530963<space/></arg><arg name="doi"><space/>10.2217/pgs.09.37<space/></arg></template></extension><space/>Such approaches promise the advent of &quot;<link><target>personalized medicine</target></link>&quot;; in which drugs and drug combinations are optimized for each individual's unique genetic makeup.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm126957.pdf</arg><arg name="format">PDF</arg><arg name="title">Guidance for Industry Pharmacogenomic Data Submissions</arg><arg name="date">March 2005</arg><arg name="publisher">[[U.S. Food and Drug Administration]]</arg><arg name="accessdate">2008-08-27</arg></template></extension><extension extension_name='ref' name="pmid20712531"><template><target>cite journal</target><arg name="author"><space/>Squassina A, Manchia M, Manolopoulos VG, Artac M, Lappa-Manakou C, Karkabouna S, Mitropoulos K, Del Zompo M, Patrinos GP<space/></arg><arg name="title"><space/>Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice<space/></arg><arg name="journal"><space/>Pharmacogenomics<space/></arg><arg name="volume"><space/>11<space/></arg><arg name="issue"><space/>8<space/></arg><arg name="pages"><space/>1149–67<space/></arg><arg name="date">August 2010<space/></arg><arg name="pmid"><space/>20712531<space/></arg><arg name="doi"><space/>10.2217/pgs.10.97<space/></arg></template></extension></paragraph><paragraph><link><target>File:InsulinHexamer.jpg</target><part>thumb</part><part>Computer-generated image of insulin hexamers highlighting the threefold<space/><link><target>symmetry</target></link>, the<space/><link><target>zinc</target></link><space/>ions holding it together, and the<space/><link><target>histidine</target></link><space/>residues involved in zinc binding.</part></link></paragraph><paragraph>Biotechnology has contributed to the discovery and manufacturing of traditional<space/><link><target>small molecule</target></link><space/><link><target>pharmaceutical drugs</target></link><space/>as well as drugs that are the product of biotechnology -<space/><link><target>biopharmaceutics</target></link>. Modern biotechnology can be used to manufacture existing medicines relatively easily and cheaply. The first genetically engineered products were medicines designed to treat human diseases. To cite one example, in 1978<space/><link><target>Genentech</target></link><space/>developed synthetic humanized<space/><link><target>insulin</target></link><space/>by joining its gene with a<space/><link><target>plasmid</target></link><space/>vector inserted into the bacterium<space/><italics><link><target>Escherichia coli</target></link></italics>. Insulin, widely used for the treatment of diabetes, was previously extracted from the pancreas of<space/><link><target>abattoir</target></link><space/>animals (cattle and/or pigs). The resulting genetically engineered bacterium enabled the production of vast quantities of synthetic human insulin at relatively low cost.<extension extension_name='ref'><template><target>cite book</target><arg name="author">Bains, W.<space/></arg><arg name="title">Genetic Engineering For Almost Everybody: What Does It Do? What Will It Do?<space/></arg><arg name="publisher">Penguin<space/></arg><arg name="year">1987<space/></arg><arg name="isbn">0-14-013501-4<space/></arg><arg name="page">99<space/></arg><arg name="url"><space/></arg></template></extension><extension extension_name='ref' name="USIS">U.S. Department of State International Information Programs, &quot;Frequently Asked Questions About Biotechnology&quot;, USIS Online; available from<space/><link type='external' href='http://usinfo.state.gov/ei/economic_issues/biotechnology/biotech_faq.html'>USinfo.state.gov</link>, accessed 13 September 2007. Cf.<space/><template><target>cite journal</target><arg name="author">Feldbaum, C.<space/></arg><arg name="title">Some History Should Be Repeated<space/></arg><arg name="journal">Science<space/></arg><arg name="volume">295<space/></arg><arg name="page">975<space/></arg><arg name="date">February 2002</arg><arg name="pmid">11834802</arg><arg name="doi">10.1126/science.1069614<space/></arg><arg name="issue">5557<space/></arg></template></extension><space/>Biotechnology has also enabled emerging therapeutics like<space/><link><target>gene therapy</target></link>. The application of biotechnology to basic science (for example through the<space/><link><target>Human Genome Project</target></link>) has also dramatically improved our understanding of<space/><link><target>biology</target></link><space/>and as our scientific knowledge of normal and disease biology has increased, our ability to develop new medicines to treat previously untreatable diseases has increased as well.<extension extension_name='ref' name="USIS"></extension></paragraph><paragraph><link><target>Genetic testing</target></link><space/>allows the<space/><link><target>Genetics</target><part>genetic</part></link><space/><link><target>medical diagnosis</target><part>diagnosis</part></link><space/>of vulnerabilities to inherited<space/><link><target>diseases</target></link>, and can also be used to determine a child's parentage (genetic mother and father) or in general a person's<space/><link><target>ancestry</target></link>. In addition to studying<space/><link><target>chromosomes</target></link><space/>to the level of individual genes, genetic testing in a broader sense includes<space/><link><target>biochemical</target></link><space/>tests for the possible presence of genetic diseases, or mutant forms of genes associated with increased risk of developing genetic disorders. Genetic testing identifies changes in<space/><link><target>chromosomes</target></link>, genes, or proteins.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.ghr.nlm.nih.gov/handbook/testing/genetictesting<space/></arg><arg name="title">What is genetic testing? - Genetics Home Reference<space/></arg><arg name="publisher">Ghr.nlm.nih.gov<space/></arg><arg name="date">2011-05-30<space/></arg><arg name="accessdate">2011-06-07</arg></template></extension><space/>Most of the time, testing is used to find changes that are associated with inherited disorders. The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person's chance of developing or passing on a<space/><link><target>genetic disorder</target></link>. As of 2011 several hundred genetic tests were in use.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.nlm.nih.gov/medlineplus/genetictesting.html<space/></arg><arg name="title">Genetic Testing: MedlinePlus<space/></arg><arg name="publisher">Nlm.nih.gov<space/></arg><arg name="accessdate">2011-06-07</arg></template></extension><extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.eurogentest.org/patient/public_health/info/public/unit3/DefinitionsGeneticTesting-3rdDraf18Jan07.xhtml<space/></arg><arg name="title">Definitions of Genetic Testing<space/></arg><arg name="accessdate">2008-08-10<space/></arg><arg name="work">Definitions of Genetic Testing (Jorge Sequeiros and Bárbara Guimarães)<space/></arg><arg name="publisher">EuroGentest Network of Excellence Project<space/></arg><arg name="date">2008-09-11<space/></arg><arg name="deadurl">yes<space/></arg><arg name="archiveurl">https://web.archive.org/20090204181251/http://eurogentest.org:80/patient/public_health/info/public/unit3/DefinitionsGeneticTesting-3rdDraf18Jan07.xhtml<space/></arg><arg name="archivedate">4 February 2009<space/></arg></template></extension><space/>Since genetic testing may open up ethical or psychological problems, genetic testing is often accompanied by<space/><link><target>genetic counseling</target></link>.</paragraph><heading level='3'>Agriculture</heading><paragraph><link><target>Genetically modified crops</target></link><space/>(&quot;GM crops&quot;, or &quot;biotech crops&quot;) are plants used in<space/><link><target>agriculture</target></link>, the<space/><link><target>DNA</target></link><space/>of which has been modified with<space/><link><target>genetic engineering</target></link><space/>techniques. In most cases the aim is to introduce a new<space/><link><target>trait (biology)</target><part>trait</part></link><space/>to the plant which does not occur naturally in the species.</paragraph><paragraph>Examples in food crops include resistance to certain pests,<extension extension_name='ref' name="news.google.co.uk"><link type='external' href='https://news.google.co.uk/newspapers?id=A0YyAAAAIBAJ&amp;amp;sjid=jOYFAAAAIBAJ&amp;amp;pg=4631,1776980&amp;amp;dq=bacillus+thuringiensis+potato+1996+approved&amp;amp;hl='>Genetically Altered Potato Ok'd For Crops</link><space/>Lawrence Journal-World 6 May 1995</extension><space/>diseases,<extension extension_name='ref'><template><target>cite book</target><arg name="author">National Academy of Sciences<space/></arg><arg name="title">Transgenic Plants and World Agriculture<space/></arg><arg name="publisher">National Academy Press<space/></arg><arg name="location">Washington<space/></arg><arg name="year">2001<space/></arg></template></extension><space/>stressful environmental conditions,<extension extension_name='ref'>Paarlburg, Robert<space/><link type='external' href='http://www.ilsi.org/Documents/2011%20AM%20Presentations/CERAPaarlberg.pdf'>Drought Tolerant GMO Maize in Africa, Anticipating Regulatory Hurdles</link><space/>International Life Sciences Institute, January 2011. Retrieved 25 April 2011</extension><space/>resistance to chemical treatments (e.g. resistance to a<space/><link><target>herbicide</target></link><extension extension_name='ref'>Carpenter J. &amp; Gianessi L. (1999).<space/><link type='external' href='http://agbioforum.org/v2n2/v2n2a02-carpenter.htm'>Herbicide tolerant soybeans: Why growers are adopting Roundup Ready varieties</link>. AgBioForum, 2(2), 65-72.</extension>), reduction of spoilage,<extension extension_name='ref' name="Haroldsen1"><template><target>cite journal</target><arg name="doi">10.3733/ca.v066n02p62<space/></arg><arg name="url">http://ucce.ucdavis.edu/files/repositoryfiles/ca6602p62-93331.pdf<space/></arg><arg name="title"><space/>Research and adoption of biotechnology strategies could improve California fruit and nut crops<space/></arg><arg name="year"><space/>2012<space/></arg><arg name="last1"><space/>Haroldsen<space/></arg><arg name="first1"><space/>Victor M.<space/></arg><arg name="last2">Paulino<space/></arg><arg name="first2">Gabriel<space/></arg><arg name="last3">Chi-ham<space/></arg><arg name="first3">Cecilia<space/></arg><arg name="last4">Bennett<space/></arg><arg name="first4">Alan B.<space/></arg><arg name="journal"><space/>California Agriculture<space/></arg><arg name="volume"><space/>66<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>62–69</arg></template></extension><space/>or improving the nutrient profile of the crop.<extension extension_name='ref'><link type='external' href='http://www.irri.org/index.php?option=com_k2&amp;amp;view=item&amp;amp;layout=item&amp;amp;id=10202&amp;amp;Itemid=100571&amp;amp;lang=en'>About Golden Rice</link>. Irri.org. Retrieved on 2013-03-20.</extension><space/>Examples in non-food crops include production of<space/><link><target>Plant manufactured pharmaceuticals</target><part>pharmaceutical agent</part><trail>s</trail></link>,<extension extension_name='ref'>Gali Weinreb and Koby Yeshayahou for Globes May 2, 2012.<space/><link type='external' href='http://www.globes.co.il/serveen/globes/docview.asp?did=1000745325&amp;amp;fid=1725'>FDA approves Protalix Gaucher treatment</link></extension><space/><link><target>biofuels</target></link>,<extension extension_name='ref'>Carrington, Damien (19 January 2012)<space/><link type='external' href='http://www.guardian.co.uk/environment/2012/jan/19/gm-microbe-seaweed-biofuels'>GM microbe breakthrough paves way for large-scale seaweed farming for biofuels</link><space/>The Guardian. Retrieved 12 March 2012</extension><space/>and other industrially useful goods,<extension extension_name='ref'><template><target>Cite journal</target><arg name="last">van Beilen</arg><arg name="first">Jan B.<space/></arg><arg name="author2">Yves Poirier</arg><arg name="title">Harnessing plant biomass for biofuels and biomaterials:Production of renewable polymers from crop plants</arg><arg name="journal">The Plant Journal<space/></arg><arg name="volume">54</arg><arg name="issue">4<space/></arg><arg name="pages">684–701<space/></arg><arg name="date"><space/>May 2008</arg><arg name="url">http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-313X.2008.03431.x</arg><arg name="doi">10.1111/j.1365-313X.2008.03431.x</arg><arg name="pmid">18476872</arg></template></extension><space/>as well as for<space/><link><target>bioremediation</target></link>.<extension extension_name='ref'>Strange, Amy (20 September 2011)<space/><link type='external' href='http://www.irishtimes.com/newspaper/ireland/2011/0913/1224304027463.html'>Scientists engineer plants to eat toxic pollution</link><space/>The Irish Times. Retrieved 20 September 2011</extension><extension extension_name='ref' name="Diaz"><template><target>cite book</target><arg name="author"><space/>Diaz E (editor).</arg><arg name="title"><space/>Microbial Biodegradation: Genomics and Molecular Biology</arg><arg name="edition"><space/>1st</arg><arg name="publisher"><space/>Caister Academic Press</arg><arg name="year"><space/>2008</arg><arg name="url">http://www.horizonpress.com/biod</arg><arg name="isbn"><space/>1-904455-17-4</arg></template></extension></paragraph><paragraph>Farmers have widely adopted GM technology. Between 1996 and 2011, the total surface area of land cultivated with GM crops had increased by a factor of 94, from<space/><template><target>convert</target><arg>17000</arg><arg>km2</arg><arg>acre</arg><arg name="sp">us</arg></template><space/>to 1,600,000&amp;nbsp;km<xhtml:sup>2</xhtml:sup><space/>(395 million acres).<extension extension_name='ref' name="James2011"></extension><space/>10% of the world's crop lands were planted with GM crops in 2010.<extension extension_name='ref' name="James2011"><template><target>cite web</target><arg name="last">James</arg><arg name="first">C</arg><arg name="title">ISAAA Brief 43, Global Status of Commercialized Biotech/GM Crops: 2011</arg><arg name="work">ISAAA Briefs</arg><arg name="publisher">International Service for the Acquisition of Agri-biotech Applications (ISAAA)</arg><arg name="location">Ithaca, New York</arg><arg name="year">2011</arg><arg name="url">http://www.isaaa.org/resources/publications/briefs/43/executivesummary/default.asp</arg><arg name="accessdate">2012-06-02</arg></template></extension><space/>As of 2011, 11 different transgenic crops were grown commercially on 395 million acres (160 million hectares) in 29 countries such as the USA, Brazil, Argentina, India, Canada, China, Paraguay, Pakistan, South Africa, Uruguay, Bolivia, Australia, Philippines, Myanmar, Burkina Faso, Mexico and Spain.<extension extension_name='ref' name="James2011"></extension></paragraph><paragraph><link><target>Genetically modified foods</target></link><space/>are foods produced from<space/><link><target>organism</target><trail>s</trail></link><space/>that have had specific changes introduced into their<space/><link><target>DNA</target></link><space/>with the methods of<space/><link><target>genetic engineering</target></link>. These techniques have allowed for the introduction of new crop traits as well as a far greater control over a food's genetic structure than previously afforded by methods such as<space/><link><target>selective breeding</target></link><space/>and<space/><link><target>mutation breeding</target></link>.<extension extension_name='ref'><link type='external' href='http://www.bis.gov.uk/files/file15655.pdf'>GM Science Review First Report</link>, Prepared by the UK GM Science Review panel (July 2003). Chairman Professor Sir David King, Chief Scientific Advisor to the UK Government, P 9</extension><space/>Commercial sale of genetically modified foods began in 1994, when<space/><link><target>Calgene</target></link><space/>first marketed its<space/><link><target>Flavr Savr</target></link><space/>delayed ripening tomato.<extension extension_name='ref' name="James 1996"><template><target>cite web</target><arg name="last">James</arg><arg name="first">Clive</arg><arg name="title">Global Review of the Field Testing and Commercialization of Transgenic Plants: 1986 to 1995</arg><arg name="url">http://www.isaaa.org/kc/Publications/pdfs/isaaabriefs/Briefs%201.pdf</arg><arg name="publisher">The International Service for the Acquisition of Agri-biotech Applications</arg><arg name="accessdate">17 July 2010</arg><arg name="year">1996</arg></template></extension><space/>To date most genetic modification of foods have primarily focused on<space/><link><target>cash crop</target><trail>s</trail></link><space/>in high demand by farmers such as<space/><link><target>Transgenic soybean</target><part>soybean</part></link>,<space/><link><target>Transgenic maize</target><part>corn</part></link>,<space/><link><target>canola</target></link>, and<space/><link><target>cotton seed oil</target></link>. These have been engineered for resistance to pathogens and herbicides and better nutrient profiles. GM livestock have also been experimentally developed, although as of November 2013 none are currently on the market.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.fda.gov/animalveterinary/developmentapprovalprocess/geneticengineering/geneticallyengineeredanimals/ucm113672.htm<space/></arg><arg name="title">Consumer Q&A<space/></arg><arg name="publisher">Fda.gov<space/></arg><arg name="date">2009-03-06<space/></arg><arg name="accessdate">2012-12-29</arg></template></extension></paragraph><paragraph>There is broad<space/><link><target>scientific consensus</target></link><space/>that food on the market derived from GM crops poses no greater risk to human health than conventional food.<extension extension_name='ref' name="AAAS">American Association for the Advancement of Science (AAAS), Board of Directors (2012).<space/><link type='external' href='http://www.aaas.org/news/releases/2012/1025gm_statement.shtml'>Legally Mandating GM Food Labels Could Mislead and Falsely Alarm Consumers</link></extension><extension extension_name='ref' name="decade_of_EU-funded_GMO_research"><template><target>cite book</target><arg name="title"><space/>A decade of EU-funded GMO research (2001-2010)</arg><arg name="url"><space/>http://ec.europa.eu/research/biosociety/pdf/a_decade_of_eu-funded_gmo_research.pdf</arg><arg name="format"><space/>PDF</arg><arg name="year"><space/>2010</arg><arg name="publisher"><space/>Directorate-General for Research and Innovation. Biotechnologies, Agriculture, Food. European Union</arg><arg name="doi"><space/>10.2777/97784</arg><arg name="isbn"><space/>978-92-79-16344-9</arg><arg name="quote">"The main conclusion to be drawn from the efforts of more than 130 research projects, covering a period of more than 25 years of research, and involving more than 500 independent research groups, is that biotechnology, and in particular GMOs, are not per se more risky than e.g. conventional plant breeding technologies." (p. 16)</arg></template></extension><extension extension_name='ref' name="Ronald"><template><target>cite journal</target><arg name="author"><space/>Ronald, Pamela<space/></arg><arg name="title"><space/>Plant Genetics, Sustainable Agriculture and Global Food Security<space/></arg><arg name="journal"><space/>Genetics<space/></arg><arg name="volume"><space/>188<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>11–20<space/></arg><arg name="year"><space/>2011<space/></arg><arg name="url">http://www.genetics.org/content/188/1/11.long<space/></arg><arg name="doi"><space/>10.1534/genetics.111.128553<space/></arg><arg name="pmid"><space/>21546547<space/></arg><arg name="pmc"><space/>3120150</arg></template></extension><extension extension_name='ref' name="AMA">American Medical Association (2012).<space/><link type='external' href='http://www.ama-assn.org/resources/doc/csaph/a12-csaph2-bioengineeredfoods.pdf'>Report 2 of the Council on Science and Public Health: Labeling of Bioengineered Foods</link><space/>&quot;Bioengineered foods have been consumed for close to 20 years, and during that time, no overt consequences on human health have been reported and/or substantiated in the peer-reviewed literature.&quot; (first page)</extension><extension extension_name='ref' name="FAO2004">FAO, 2004.<space/><link type='external' href='http://www.fao.org/docrep/006/Y5160E/y5160e10.htm#P3_1651The'>State of Food and Agriculture 20032004. Agricultural Biotechnology: Meeting the Needs of the Poor</link>. Food and Agriculture Organization of the United Nations, Rome. &quot;Currently available transgenic crops and foods derived from them have been judged safe to eat and the methods used to test their safety have been deemed appropriate. These conclusions represent the consensus of the scientific evidence surveyed by the ICSU (2003) and they are consistent with the views of the World Health Organization (WHO, 2002). These foods have been assessed for increased risks to human health by several national regulatory authorities (inter alia, Argentina, Brazil, Canada, China, the United Kingdom and the United States) using their national food safety procedures (ICSU). To date no verifiable untoward toxic or nutritionally deleterious effects resulting from the consumption of foods derived from genetically modified crops have been discovered anywhere in the world (GM Science Review Panel). Many millions of people have consumed foods derived from GM plants - mainly maize, soybean and oilseed rape - without any observed adverse effects (ICSU).&quot;</extension><space/>GM crops also provide a number of ecological benefits, if not used in excess.<extension extension_name='ref' name="nytimes.com">Andrew Pollack for the New York Times. April 13, 2010<space/><link type='external' href='http://www.nytimes.com/2010/04/14/business/energy-environment/14crop.html?pagewanted=all&amp;amp;_r=0'>Study Says Overuse Threatens Gains From Modified Crops</link></extension><space/>However, opponents have objected to GM crops per se on several grounds, including environmental concerns, whether food produced from GM crops is safe, whether GM crops are needed to address the world's food needs, and economic concerns raised by the fact these organisms are subject to intellectual property law.</paragraph><heading level='3'>Industrial biotechnology</heading><paragraph>Industrial biotechnology (known mainly in Europe as white biotechnology) is the application of biotechnology for industrial purposes, including<space/><link><target>industrial fermentation</target></link>. It includes the practice of using<space/><link><target>Cell (biology)</target><part>cells</part></link><space/>such as<space/><link><target>micro-organisms</target></link>, or components of cells like<space/><link><target>enzymes</target></link>, to generate<space/><link><target>Industry</target><part>industrially</part></link><space/>useful products in sectors such as chemicals, food and feed, detergents, paper and pulp, textiles and<space/><link><target>biofuels</target></link>.<extension extension_name='ref'><link type='external' href='http://www.unido.org/fileadmin/media/documents/pdf/Energy_Environment/Industrial_biotech_and_biomass_utilisation_EGM_report.pdf'>Industrial Biotechnology and Biomass Utilisation</link></extension><space/>In doing so, biotechnology uses renewable raw materials and may contribute to lowering greenhouse gas emissions and moving away from a petrochemical-based economy.<extension extension_name='ref'><link type='external' href='http://www.innovationeu.org/news/innovation-eu-vol2-1/0262-industrial-biotechnology.html'>Industrial biotechnology, A powerful, innovative technology to mitigate climate change</link></extension></paragraph><heading level='3'>Regulation</heading><paragraph><template><target>main</target><arg>Regulation of genetic engineering</arg><arg>Regulation of the release of genetic modified organisms</arg></template></paragraph><paragraph>The regulation of genetic engineering concerns approaches taken by governments to assess and manage the risks associated with the use of<space/><link><target>genetic engineering</target></link><space/>technology, and the development and release of genetically modified organisms (GMO), including<space/><link><target>genetically modified crops</target></link><space/>and<space/><link><target>genetically modified fish</target></link>. There are differences in the regulation of GMOs between countries, with some of the most marked differences occurring between the USA and Europe.<extension extension_name='ref'><template><target>Cite journal</target><arg name="last1"><space/>Gaskell<space/></arg><arg name="first1"><space/>G. 
</arg><arg name="last2"><space/>Bauer<space/></arg><arg name="first2"><space/>M. W. 
</arg><arg name="last3"><space/>Durant<space/></arg><arg name="first3"><space/>J. 
</arg><arg name="last4"><space/>Allum<space/></arg><arg name="first4"><space/>N. C. 
</arg><arg name="title"><space/>Worlds Apart? The Reception of Genetically Modified Foods in Europe and the U.S 
</arg><arg name="doi"><space/>10.1126/science.285.5426.384 
</arg><arg name="journal"><space/>Science 
</arg><arg name="volume"><space/>285 
</arg><arg name="issue"><space/>5426 
</arg><arg name="pages"><space/>384–387 
</arg><arg name="year"><space/>1999 
</arg><arg name="pmid"><space/>10411496
</arg><arg name="pmc"><space/>
</arg></template></extension><space/>Regulation varies in a given country depending on the intended use of the products of the genetic engineering. For example, a crop not intended for food use is generally not reviewed by authorities responsible for food safety.<extension extension_name='ref' name="PotatoPro"><link type='external' href='http://www.potatopro.com/newsletters/20100310.htm'>PotatoPro</link></extension><space/>The European Union differentiates between approval for cultivation within the EU and approval for import and processing. While only a few GMOs have been approved for cultivation in the EU a number of GMOs have been approved for import and processing.<extension extension_name='ref' name="Wesseler-2011"><link><target>Justus Wesseler</target><part>Wesseler</part></link>, J. and N. Kalaitzandonakes (2011): Present and Future EU GMO policy. In Arie Oskam, Gerrit Meesters and Huib Silvis (eds.), EU Policy for Agriculture, Food and Rural Areas. Second Edition, pp.&amp;nbsp;23323 23-332. Wageningen: Wageningen Academic Publishers</extension><space/>The cultivation of GMOs has triggered a debate about coexistence of GM and non GM crops. Depending on the coexistence regulations incentives for cultivation of GM crops differ.<extension extension_name='ref' name="Beckman-2011">Beckmann, V., C. Soregaroli, J.<space/><link><target>Justus Wesseler</target><part>Wesseler</part></link><space/>(2011): Coexistence of genetically modified (GM) and non-modified (non GM) crops: Are the two main property rights regimes equivalent with respect to the coexistence value? In &quot;Genetically modified food and global welfare&quot; edited by Colin Carter, GianCarlo Moschini and Ian Sheldon, pp&amp;nbsp;201224. Volume 10 in Frontiers of Economics and Globalization Series. Bingley, UK: Emerald Group Publishing</extension></paragraph><heading level='2'>Learning</heading><paragraph>In 1988, after prompting from the<space/><link><target>United States Congress</target></link>, the<space/><link><target>National Institute of General Medical Sciences</target></link><space/>(<link><target>National Institutes of Health</target></link>) (NIGMS) instituted a funding mechanism for biotechnology training. Universities nationwide compete for these funds to establish<space/><link><target>Biotechnology Training Program</target><trail>s</trail></link><space/>(BTPs). Each successful application is generally funded for five years then must be competitively renewed.<space/><link><target>Graduate students</target></link><space/>in turn compete for acceptance into a BTP; if accepted, then stipend, tuition and health insurance support is provided for two or three years during the course of their<space/><link><target>Ph.D.</target></link><space/>thesis work. Nineteen institutions offer NIGMS supported BTPs.<extension extension_name='ref'><template><target>Cite web</target><arg name="url"><space/>http://www.nigms.nih.gov/Training/InstPredoc/Pages/PredocDesc-Biotechnology.aspx</arg><arg name="title"><space/>Biotechnology Predoctoral Training Program</arg><arg name="date"><space/>18 December 2013</arg><arg name="accessdate"><space/>28 October 2014</arg><arg name="website"><space/>National Institute of General Medical Sciences</arg><arg name="publisher"><space/></arg><arg name="last"><space/></arg><arg name="first"><space/></arg></template></extension><space/>Biotechnology training is also offered at the undergraduate level and in community colleges.</paragraph><heading level='2'>See also</heading><paragraph><template><target>Portal</target><arg>Biotechnology</arg><arg>Agriculture</arg><arg>Food</arg><arg>Medicine</arg></template><template><target>colbegin</target><arg>2</arg></template></paragraph><list type='bullet'><listitem><link><target>Bioculture</target></link></listitem><listitem><link><target>Bioeconomics (biophysical)</target></link></listitem><listitem><link><target>Biological engineering</target></link></listitem><listitem><link><target>Biomimetics</target></link></listitem><listitem><link><target>Bionic architecture</target></link></listitem><listitem><link><target>Biotechnology industrial park</target></link></listitem><listitem><link><target>Competitions and prizes in biotechnology</target></link></listitem><listitem><link><target>C-5 sterol desaturase#Potential applications</target><part>C5SD</part></link></listitem><listitem><link><target>EHA101</target></link></listitem><listitem><link><target>Genetic engineering</target></link></listitem><listitem><link><target>Green Revolution</target></link></listitem><listitem><link><target>History of biotechnology</target></link></listitem><listitem><link><target>List of biotechnology articles</target></link></listitem><listitem><link><target>List of biotechnology companies</target></link></listitem><listitem><link><target>Metabolic engineering</target></link></listitem><listitem><link><target>NASDAQ Biotechnology Index</target></link></listitem><listitem><link><target>Outline of biotechnology</target></link></listitem><listitem><link><target>Pharmaceutical chemistry</target></link></listitem><listitem><link><target>Pharmaceutical companies</target></link></listitem><listitem><link><target>SWORD-financing</target></link></listitem><listitem><link><target>Timeline of biotechnology</target></link></listitem><listitem><link><target>Virotherapy</target></link></listitem></list><paragraph><template><target>colend</target></template></paragraph><heading level='2'>References and notes</heading><paragraph><template><target>Reflist</target><arg>35em</arg></template></paragraph><heading level='2'>Further reading</heading><list type='bullet'><listitem><template><target>cite book</target><arg name="last">Friedman<space/></arg><arg name="first">Yali</arg><arg name="title">Building Biotechnology: Starting, Managing, and Understanding Biotechnology Companies<space/></arg><arg name="url">http://www.buildingbiotechnology.com<space/></arg><arg name="publisher">Logos Press<space/></arg><arg name="location">Washington, DC<space/></arg><arg name="year">2008<space/></arg><arg name="isbn">978-0-9734676-3-5</arg></template></listitem><listitem><template><target>cite book</target><arg name="author">Oliver, Richard W.<space/></arg><arg name="title">The Coming Biotech Age<space/></arg><arg name="isbn">0-07-135020-9<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="author">Powell, Walter W.; White, Douglas R.; Koput, Kenneth W.; Owen-Smith, Jason<space/></arg><arg name="title">Network Dynamics and Field Evolution: The Growth of Interorganizational Collaboration in the Life Sciences<space/></arg><arg name="journal">American Journal of Sociology<space/></arg><arg name="volume">110<space/></arg><arg name="issue">4<space/></arg><arg name="pages">1132–1205<space/></arg><arg name="year">2005<space/></arg><arg name="doi">10.1086/421508</arg></template><space/>Viviana Zelizer Best Paper in Economic Sociology Award (20052006), American Sociological Association.</listitem><listitem>Rasmussen, Nicolas,<space/><italics>Gene Jockeys: Life Science and the rise of Biotech Enterprise.</italics><space/>Baltimore, MD: Johns Hopkins University Press, 2014.</listitem><listitem><template><target>cite book</target><arg name="last">Zaid<space/></arg><arg name="first">A<space/></arg><arg name="author2">H.G. Hughes<space/></arg><arg name="author3">E. Porceddu<space/></arg><arg name="author4">F. Nicholas</arg><arg name="title"><space/>Glossary of Biotechnology for Food and Agriculture — A Revised and Augmented Edition of the Glossary of Biotechnology and Genetic Engineering. Available in English, French, Spanish, Chinese, Arabic, Russian, Polish, Serbian, Vietnamese and Kazakh<space/></arg><arg name="url"><space/>http://www.fao.org/biotech/biotech-glossary/en/</arg><arg name="year">2001<space/></arg><arg name="publisher">[[FAO]]<space/></arg><arg name="location"><space/>[[Rome]]</arg><arg name="isbn">92-5-104683-2</arg></template></listitem><listitem>USDA Economic Research Service,<space/><italics>Agricultural Biotechnology: An Economic Perspective.</italics><space/>Agricultural Economic Report, 1994.</listitem></list><heading level='2'>External links</heading><paragraph><template><target>wikibooks</target><arg>Genes, Technology and Policy</arg></template><template><target>WVD</target></template><template><target>Wiktionary</target><arg>biotechnology</arg></template></paragraph><list type='bullet'><listitem><link type='external' href='http://www.ussb.ir'>University Students Society Of Biotechnology</link></listitem><listitem><link type='external' href='http://www.biot.tk'>The International Forum on Biotechnology</link></listitem><listitem><link type='external' href='http://www.fbae.org/'>Foundation for Biotechnology Awareness and Education</link>,</listitem><listitem><link type='external' href='http://www.fao.org/docrep/006/y5160e/y5160e00.HTM'>A report on Agricultural Biotechnology</link><space/>focusing on the impacts of &quot;Green&quot; Biotechnology with a special emphasis on economic aspects. fao.org.</listitem><listitem><link type='external' href='http://www.economics.noaa.gov/?goal=ecosystems&amp;amp;file=users/business/biotech'>US Economic Benefits of Biotechnology to Business and Society</link><space/>NOAA Economics, economics.noaa.gov</listitem><listitem><link type='external' href='http://croplife.intraspin.com/Biotech/'>Database of the Safety and Benefits of Biotechnology</link><space/>a database of peer-reviewed scientific papers and the safety and benefits of biotechnology.</listitem><listitem><link type='external' href='http://www.whatisbiotechnology.org/'>What is Biotechnology? - A curated collection of resources about the people, places and technologies that have enabled biotechnology to transform the world we live in today</link></listitem></list><paragraph><template><target>Biotechnology</target></template><template><target>Biology topics</target></template><template><target>Technology-footer</target></template></paragraph><paragraph><template><target>Authority control</target></template></paragraph><paragraph><link><target>Category:Biotechnology</target><part></part></link><link><target>Category:Life sciences industry</target></link></paragraph></article>